Filing Details
- Accession Number:
- 0001493152-21-015620
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-29 19:42:09
- Reporting Period:
- 2021-06-28
- Accepted Time:
- 2021-06-29 19:42:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444307 | Oncosec Medical Inc | ONCS | Pharmaceutical Preparations (2834) | 980573252 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1652973 | A Brian Leuthner | 24 North Main Street Pennington NJ 08534-2218 | Interim Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-28 | 192,000 | $0.00 | 192,000 | No | 4 | A | Direct | |
Common Stock | Disposition | 2021-06-28 | 13,613 | $3.16 | 178,387 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2021-06-28 | 33,000 | $0.00 | 33,000 | $3.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
33,000 | 2021-06-28 | 2031-06-28 | No | 4 | A | Direct |
Footnotes
- Reflects restricted stock units (RSUs) that were 25% vested upon grant with the remaining 75% vesting in equal quarterly installments over the next two years.
- In connection with the vesting of 48,000 RSUs on June 28, 2021, a total of 13,613 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.
- The option is 25% vested upon grant with the remaining 75% vesting in equally in quarterly installments over the next two years.